Bone marrow stromal cells protect acute myeloid leukemia cells from anti‐CD44 therapy partly through regulating PI3K/Akt–p27<sup>Kip1</sup> axis
2014 · Molecular Carcinogenesis · 53 citations
https://doi.org/10.1002/mc.22239
P
Ping Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
398
Citations
10
h-index
11
i10-index
Ping Chen is an academic researcher from Huaian First People’s Hospital. The author has contributed to research in topics: MicroRNA in disease regulation & Lymphoma Diagnosis and Treatment & Multiple Myeloma Research and Treatments. The author has an h-index of 10, co-authored 43 publications.
ORCID: 0000-0002-0737-4991Papers by this author
worksISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex
2014 · Molecular Cancer · 38 citations
https://doi.org/10.1186/1476-4598-13-181
Identification of a Novel 974C?G Nonsense Mutation of the MRP2/ABCC2 Gene in a Patient with Dubin-Johnson Syndrome and Analysis of the Effects of Rifampicin and Ursodeoxycholic Acid on Serum Bilirubin and Bile Acids
2006 · The American Journal of Gastroenterology · 34 citations
https://doi.org/10.1111/j.1572-0241.2006.00695.x
The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
2015 · Journal of Immunology Research · 21 citations
https://doi.org/10.1155/2015/416123
Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
2015 · Oncotarget · 19 citations
https://doi.org/10.18632/oncotarget.4641
Correction: Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
2018 · Nature Communications · 4 citations
https://doi.org/10.1038/ncomms16192
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat